Pharmaceuticals
Japan's Eisai to invest in U.S. Alzheimer's blood testing firm C2N
Expanded use of tests could boost drugmaker's lecanemab medication
Aging societies from Japan to Singapore rush to safeguard mature women's wellness
Bevy of 'promising companies,' including Gene Solutions, attract investments
Demanding the government scrap the plan to increase medical school admissions
Yoon's tough stance proves popular amid reports of hospital disruptions
Many quit as Yoon pushes plan to train more physicians to ease shortage
Health authorities scrambling to prevent major disruptions to services
PorMedTec plans interspecies kidney transplants on humans from 2025
Genex's software identifies relationships between genetic mutations and disorders
Better supplies could prevent countless deaths from common illnesses
Set to become first major technology company to roll out such a device
New tools are making information more accessible, understandable and engaging
In supportive environments, service providers are proving financially sustainable
Garwood seeking to treat infections after prosthetic joint implant surgery
Brewer to more than double Asian markets for its plasma lactic acid
Tokyo aims for more of its drugs to enter Asian markets, but experts skeptical
Changes aim to encourage foreign pharma startups to enter market
NTT Data seeks insights for health, product development
Prescription-free sales are step forward for reproductive rights, but hurdles remain
Drugmaker aims to expand health food for women with its unit Pharmavite
Clusters of children in north presenting symptoms prompt WHO questions
Summit's first health ministerial follows record summer spike in heatstroke and dengue cases
Geographic proximity, linguistic similarities, quality and costs among advantages
More than 1,000 die in Bangladesh; major outbreak hits Taiwan
Drug hoped to slow nearsightedness affecting 2bn people worldwide
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.